New England Securities Corporation »

GlaxoSmithKline shares owned by New England Securities Corporation

Quarter-by-quarter ownership of GlaxoSmithKline shares owned by New England Securities Corporation from 13F filings

Historical chart of New England Securities Corporation investment in GlaxoSmithKline

Tip: Access up to 7 years of quarterly data

All positions including GlaxoSmithKline held by New England Securities Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GlaxoSmithKline by New England Securities Corporation

Quarter filed Position value Share count Share price at filing
2014-12-31 $225k 5.3k 42.83
2014-09-30 $147k 3.2k 45.89
2014-06-30 $134k 2.5k 53.43
2014-03-31 $142k 2.7k 53.26
2013-12-31 $110k 2.1k 53.50
2013-09-30 $103k 2.1k 50.10
2013-06-30 $58k 1.2k 50.39

More positions owned by New England Securities Corporation

Spdr S&p 500 Etf (SPY)
Vanguard Dividend Appreciation ETF (VIG)
Parsley Energy Inc-class A
SPDR S&P Dividend (SDY)
Apple (AAPL)
iShares Russell 1000 Growth Index (IWF)
Rydex S&P 500 Pure Growth ETF
Vanguard FTSE All-World ex-US ETF (VEU)
WisdomTree LargeCap Dividend Fund (DLN)
iShares Russell Midcap Index Fund (IWR)
PowerShares Dynamic Pharmaceuticals
iShares MSCI EAFE Index Fund (EFA)
Vanguard Growth ETF (VUG)
Vanguard Small-Cap Growth ETF (VBK)
iShares S&P MidCap 400 Growth (IJK)

View all positions for New England Securities Corporation

Top funds holding GlaxoSmithKline

Kahn Brothers Group
Damian Sousa
Columbia Asset Management
Paradigm Asset Management Company
Park Circle
Asset Planning
Byrne Asset Management
Huntington National Bank

View all funds holding GlaxoSmithKline